Skip to main content

Advertisement

SpringerLink
Log in

Inhibition of interleukin-2-induced T-cell proliferation by sera from patients with the acquired immune deficiency syndrome

  • Original Articles
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

Sera from 22 patients with either lymphadenopathy syndrome (LAS), acquired immune deficiency syndrome (AIDS)-related complex (ARC), or acquired immune deficiency syndrome were examined for their effect on the interleukin-2 (IL-2)-induced proliferative response of an IL-2-dependent cytotoxic T-cell line, CTL-20. All of the patient sera included in this study were positive for the presence of antibodies against human T-cell lymphotropic virus type III (HTLV-III) as determined by an HTLV-III-specific enzyme-linked immunosorbent assay (ELISA). Eighteen of the 22 patient sera examined (81.8%) exhibited at least a modest suppressive effect on the proliferative response of CTL-20 cells. The inhibitory effect was dose-dependent and varied in intensity for each individual serum. In many cases, the magnitude of suppression was absolute in that it totally abrogated IL-2-induced DNA synthesis. Normal human serum (NHS) exerted no suppressive influence on the IL-2-induced proliferative response of identical control cultures. This same panel of 22 patient sera exhibited no significant inhibitory effects on the levels of protein synthesis in cultures of a non-IL-2-dependent human T-cell line, CCRF-HSB-2, indicating that the suppressive effect was not mediated by nonspecific serum cytotoxicity. The inhibitory effect of patient sera in the IL-2-dependent target cell assay correlated with the ability of these same sera to suppress the mitogen-induced proliferative response of normal human peripheral blood lymphocytes (PBL). These observations are particularly striking in view of the recognized defects of IL-2-dependent effector T-cell functions in AIDS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Friedman-Kien AE, Laubenstein LJ, Rubinstein P, Buimovici-Klein E, Marmor M, Stahl R, Spigland I, Kim KS, Zolla-Pazner S: Disseminated Kaposi's sarcoma in homosexual men. Ann Intern Med 96:693–700, 1982

    Google Scholar 

  2. Gottlieb MS, Schroff F, Schanker HM, Weisman JD, Fan PT, Wolf RA, Saxon A: Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: Evidence of a new acquired cellular immunodeficiency. N Engl J Med 305:1425–1430, 1981

    Google Scholar 

  3. Mildvan D, Mathur U, Enlow RW, Romain PL, Winchester RJ, Colp C, Singman H, Adelsberg B, Spigland I: Opportunistic infections and immune deficiency in homosexual men. Ann Intern Med 96:700–704, 1982

    Google Scholar 

  4. Kornfeld H, Vande Stouwe RA, Lange M, Reddy MM, Grieco MH: T lymphocyte subpopulations in homosexual men. N Engl J Med 307:729–731, 1982

    Google Scholar 

  5. Schroff RW, Gottlieb MS, Prince HE, Chai LL, Fahey JL: Immunological studies of homosexual men with immunodeficiency and Kaposi's sarcoma. Clin Immunol Immunopathol 27:300–314, 1983

    Google Scholar 

  6. Fahey JL, Prince H, Weaver MS, Groopman J, Visscher B, Schwartz K, Detels R: Quantitative changes in T helper or T suppressor lymphocyte subsets that distinguish acquired immune deficiency syndrome from other subset disorders. Am J Med 76:95–100, 1984

    Google Scholar 

  7. Nicholson JKA, McDougal JS, Spira TJ, Cross GD, Jones BM, Reinherz EL: Immunoregulatory subsets of the T helper and T suppressor cell populations in homosexual men with chronic unexplained lymphadenopathy. J Clin Invest 73:191–201, 1984

    Google Scholar 

  8. Seligmann M, Chess L, Fahey JL, Fauci AS, Lachmann PJ, L'Age-Stehr J, Ngu J, Pinching AJ, Rosen FS, Spira TJ, Wybran J: AIDS—an immunologic reevaluation. N Engl J Med 311:1286–1292, 1984

    Google Scholar 

  9. Fauci AS, Macher AE, Longo DL, Lane HC, Rook AH, Masur H, Gelmann EP: Acquired immunodeficiency syndrome: Epidemiologic, clinical, immunologic and therapeutic considerations. Ann Intern Med 100:92–106, 1984

    Google Scholar 

  10. Stahl RE, Friedman-Kien A, Dubin R, Marmor M, Zolla-Pazner S: Immunologic abnormalities in homosexual men: Relationship to Kaposi's sarcoma. Am J Med 73:171–178, 1982

    Google Scholar 

  11. Ammann AJ, Abrams D, Conant M, Chudwin D, Cowan M, Volberding P, Lewis B, Casavant C: Acquired immune dysfunction in homosexual men: Immunologic profiles. Clin Immunol Immunopathol 27:315–325, 1983

    Google Scholar 

  12. Fauci AS: Immunologic abnormalities in the acquired immunodeficiency syndrome (AIDS). Clin Res 32:491–499, 1984

    Google Scholar 

  13. Lane HC, Masur H, Edgar LC, Whalen G, Rook AH, Fauci AS: Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med 309:453–458, 1983

    Google Scholar 

  14. Zolla-Pazner S: B cells in the pathogenesis of AIDS. Immunol Today 5:289–291, 1984

    Google Scholar 

  15. Benveniste E, Schroff R, Stevens RH, Gottlieb MS: Immunoregulatory T cells in men with a new acquired immunodeficiency syndrome. J Clin Immunol 3:359–367, 1983

    Google Scholar 

  16. Abo W, Burkes R, Levine AM, Gill P, Linker-Israeli M, Parker JW, Horwitz DA: Abnormal B cell function and impaired interleukin-1 production in homosexual males with asymptomatic persistent generalized lymphadenopathy (APGL). Clin Res 32:503A, 1984

  17. Williams RC, Masur H, Spira TJ: Lymphocyte-reactive antibodies in acquired immune deficiency syndrome. J Clin Immunol 4:118–123, 1984

    Google Scholar 

  18. Kloster BE, Tomar RH, Spira TJ: Lymphocytotoxic antibodies in the acquired immune deficiency syndrome (AIDS). Clin Immunol Immunopathol 30:330–335, 1984

    Google Scholar 

  19. Dorsett B, Cronin W, Chuma V, Ioachim HL: Anti-lymphocyte antibodies in patients with acquired immune deficiency syndrome. Am J Med 78:621–626, 1985

    Google Scholar 

  20. Gupta S, Licorish K: Circulating immune complexes in AIDS. N Engl J Med 310:1530–1531, 1984

    Google Scholar 

  21. Euler HH, Kern P, Loffler H, Dietrich M: Precipitable immune complexes in healthy homosexual men, acquired immune deficiency syndrome and the related lymphadenopathy syndrome. Clin Exp Immunol 59:267–275, 1985

    Google Scholar 

  22. McDougal JS, Hubbard M, Nicholson JKA, Jones BM, Holman RC, Roberts J, Fishbein DB, Jaffe HW, Kaplan JE, Spira TJ, Evatt BL: Immune complexes in the acquired immunodeficiency syndrome (AIDS): Relationship to disease manifestation, risk group and immunologic defect. J Clin Immunol 5:130–138, 1985

    Google Scholar 

  23. Walsh CR, Nardi MA, Karpatkin S: On the mechanism of thrombocytopenic purpura in sexually active homosexual men. N Engl J Med 311:635–639, 1984

    Google Scholar 

  24. Cunningham-Rundles S, Michelis MA, Masur H: Serum suppression of lymphocyte activation in vitro in acquired immunodeficiency disease. J Clin Immunol 3:156–165, 1983

    Google Scholar 

  25. Hennig AK, Tomar RH: Inhibition of in vitro lymphocyte proliferation by serum from acquired immune deficiency syndrome patients depends on the ratio of cells to serum in culture. Clin Immunol Immunopathol 33:258–267, 1984

    Google Scholar 

  26. Wiedmeyer J, Hank J, Nunnink C, Kagen S, Reitnauer P, Chen B, Sondel P: Suppressive activity in the serum of individuals at risk for acquired immunodeficiency syndrome. Fed Proc 43:2946, 1984

    Google Scholar 

  27. Cantrell DA, Smith KA: The interleukin-2 T cell system: A new cell growth model. Science 224:1312–1316, 1984

    Google Scholar 

  28. CDC: Update on acquired immune deficiency syndrome (AIDS)—United States. MMWR 31:507–514, 1982

    Google Scholar 

  29. Sarngaharan MG, Popovic M, Bruch L, Schupbach J, Gallo RC: Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS. Science 224:506–508, 1984

    Google Scholar 

  30. Boyum A: Separation of lymphocytes from blood and bone marrow. Scan J Clin Lab Invest 21 (Suppl 97):77–89, 1968

    Google Scholar 

  31. Gillis S, Ferm MM, Ou W, Smith KA: T cell growth factor: Parameters of production and a quantitative microassay for activity. J Immunol 120:2027–2032, 1978

    Google Scholar 

  32. Tsang KY, Fudenberg HH, Galbraith GMP, Donnelly RP, Bishop LR, Koopman WR: Partial restoration of impaired interleukin-2 production and Tac antigen expression in AIDS patients by isoprinosine treatment in vitro. J Clin Invest 75:1538–1544, 1985

    Google Scholar 

  33. Prince HE, Kermani-Arab V, Fahey JL: Depressed interleukin-2 receptor expression in acquired immune deficiency and lymphodenopathy syndromes. J Immunol 133:1313–1317, 1984

    Google Scholar 

  34. Ciobanu N, Welte K, Kruger G, Venuta S, Gold J, Feldman S, Wang CY, Koziner B, Moore MAS, Safai B, Mertelsmann, R: Defective T cell response to PHA and mitogenic monoclonal antibodies in male homosexuals with acquired immunodeficiency syndrome and its in vitro correction by interleukin 2. J Clin Immunol 3:332–340, 1983

    Google Scholar 

  35. Munn CG, Reuben JM, Hersh EM: Expression of T cell surface antigens by mitogen stimulated lymphocytes from patients with AIDS. Fed Proc 43:1902, 1984

    Google Scholar 

  36. Kiprov DD, Busch DF, Simpson DM, Morand PR, Tardelli GP, Gullett JH, Lippert R, Mielke H: Antilymphocyte serum factors in patients with acquired immunodeficiency syndrome.In Acquired Immunodeficiency Syndrome (UCLA Symposium), MS Gottlieb, JE Groopman (eds). New York, Alan R. Liss, 1984

    Google Scholar 

  37. Schupbach J, Haller O, Vogt M, Luthy R, Joller H, Oelz O, Popovic M, Sarngaharan MG, Gallo R: Antibodies to HTLV-III in Swiss patients with AIDS and pre-AIDS and in groups at risk for AIDS. N Engl J Med 312:265–270, 1985

    Google Scholar 

  38. Donnelly RP, Tsang KY, Fudenberg HH, Wallace JI: Inhibition of interleukin 2-induced T cell proliferation by serum from patients with the acquired immune deficiency syndrome (AIDS). Fed Proc 44:6601, 1985

    Google Scholar 

  39. Hennig AK, Tomar RH: Serum from AIDS patients inhibits mitogen-stimulated lymphocyte proliferation: Characterization of the inhibition. Fed Proc 44:7643, 1985

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Basic and Clinical Immunology and Microbiology, Medical University of South Carolina, 171 Ashley Avenue, 29425, Charleston, South Carolina

    Raymond P. Donnelly, K. Y. Tsang & G. M. P. Galbraith

  2. St. Vincent's Hospital and Medical Center, 10011, New York, New York

    J. I. Wallace

Authors
  1. Raymond P. Donnelly
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. Y. Tsang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. M. P. Galbraith
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. I. Wallace
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Publication No. 746 from the Department of Basic and Clinical Immunology and Microbiology, Medical University of South Carolina.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Donnelly, R.P., Tsang, K.Y., Galbraith, G.M.P. et al. Inhibition of interleukin-2-induced T-cell proliferation by sera from patients with the acquired immune deficiency syndrome. J Clin Immunol 6, 92–101 (1986). https://doi.org/10.1007/BF00915369

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00915369

Key words

Search

Navigation